Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DILACOR XR

DILTIAZEM HYDROCHLORIDE

Standard Dose
240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview DILACOR XR is listed in Drugs@FDA under application 020092 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2011-06-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview DILACOR XR is listed in Drugs@FDA under application 020092 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2011-06-07 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.
DILACOR XR (DILTIAZEM HYDROCHLORIDE) | Drug Monograph | MedicHelpline